Skip to main content
. 2021 Jan 11;6:9. doi: 10.1038/s41541-020-00266-4

Table 3.

Anti-HBs titers in low- and high-risk obesity class patients.

Anti-HBs levels (IU/L) Low-risk obesity, BMI < 35, N = 40 High-risk obesity, BMI > 35, N = 28
1000 (high responders) 21 (52.5%) 7 (25%)
100–999 (normal responders) 12 (30%) 10 (35.7%)
10–99 (low responders) 1 (2.5%) 7 (25%)
<10 (nonresponders) 6 (15%) 4 (14.2%)

*classification of vaccine responders and non-responders as per Liu et al., 201722.